Cargando…
Novel Cellular Therapies for Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related death worldwide. Most patients present with incurable disease and the prognosis remains poor. Immunotherapy using immune checkpoint inhibitors has become standard of care for advanced disease but only a min...
Autores principales: | Roddy, Harriet, Meyer, Tim, Roddie, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833505/ https://www.ncbi.nlm.nih.gov/pubmed/35158772 http://dx.doi.org/10.3390/cancers14030504 |
Ejemplares similares
-
The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics
por: Mehra, Vedika, et al.
Publicado: (2023) -
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
por: Hendrickson, Peter G., et al.
Publicado: (2019) -
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022) -
Cellular origins of regenerating liver and hepatocellular carcinoma
por: Holczbauer, Ágnes, et al.
Publicado: (2021) -
Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
por: Shafat, Manar S., et al.
Publicado: (2020)